Cite
HARVARD Citation
Sepesi, B. et al. (n.d.). 277 Combined neoadjuvant chemo-immunotherapy therapy achieves superior downstaging of resectable non-small cell lung cancer as compared to chemotherapy, mono or dual immunotherapy. Journal for immunotherapy of cancer. p. A169. [Online].